tetraphase pharmaceuticals i
(TTPH:Consolidated Issue Listed on NASDAQ Global Select )
David P. Nicolau PharmD.
Member of Clinical Advisory Board, Tetraphase Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 22 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Dr. David P. Nicolau, PharmD serves as Director for the Center for Anti-Infective Research and Development and Coordinator for Research in the Department of Medicine, Division of Infectious Diseases and Pharmacy at Hartford Hospital in Hartford, Connecticut. Dr. Nicolau's research activities involve a wide range of preclinical drug development studies to assess the in vitro potency, in vivo efficacy and toxicity profiles of novel compounds. He serves as a Principal Investigator ...
480 Arsenal StreetPhone: 617-715-3600
Watertown, Massachusetts 02472
Board Members Memberships*There is no Board Members Memberships data available.
Medical University of South Carolina
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|